{"id":82243,"date":"2022-08-09T00:11:52","date_gmt":"2022-08-09T04:11:52","guid":{"rendered":"https:\/\/www.hedgeco.net\/news\/?p=82243"},"modified":"2022-08-09T00:14:32","modified_gmt":"2022-08-09T04:14:32","slug":"novavax-cuts-2022-revenue-guidance-in-half-stock-tanks-in-after-hours-trading","status":"publish","type":"post","link":"https:\/\/hedgeco.net\/news\/08\/2022\/novavax-cuts-2022-revenue-guidance-in-half-stock-tanks-in-after-hours-trading.html","title":{"rendered":"Novavax cuts 2022 revenue guidance in half, stock tanks in after-hours trading"},"content":{"rendered":"\n<p>(CNBC) <a rel=\"noreferrer noopener\" href=\"https:\/\/www.cnbc.com\/quotes\/NVAX\" target=\"_blank\">Novavax<\/a> deeply cut its full-year revenue guidance Monday, with no new Covid-19 vaccine sales expected for 2022 in the U.S. or from an international alliance called Covax that represents low- and middle-income countries. The Maryland biotech company cut its 2022 sales outlook by about 50% and now expects to generate $2 billion to $2.3 billion in revenue. Novavax previously forecast $4 billion to $5 billion in revenue.<\/p>\n\n\n\n<p><a href=\"https:\/\/www.cnbc.com\/2022\/08\/08\/novavax-cuts-2022-revenue-guidance-in-half-stock-tanks-in-after-hours-trading.html\">To read this article:<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(CNBC) Novavax deeply cut its full-year revenue guidance Monday, with no new Covid-19 vaccine sales expected for 2022 in the U.S. or from an international alliance called Covax that represents low- and middle-income countries. The Maryland biotech company cut its [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-82243","post","type-post","status-publish","format-standard","hentry","category-syndicated"],"_links":{"self":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/82243","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/comments?post=82243"}],"version-history":[{"count":1,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/82243\/revisions"}],"predecessor-version":[{"id":82244,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/posts\/82243\/revisions\/82244"}],"wp:attachment":[{"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/media?parent=82243"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/categories?post=82243"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hedgeco.net\/news\/wp-json\/wp\/v2\/tags?post=82243"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}